Cleanroom specialist and filtration expert collaborate on bioprocessing

Published: 27-Sep-2018

Pall Corporation and G-CON Manufacturing to deliver custom scalable turnkey PODs for flexible continuous bioprocessing and viral vector facility solutions

Modular cleanroom constructor G-CON Manufacturing and Pall Corporation are collaborating to bring turnkey continuous bioprocessing for viral vector production facility solutions to the industry.

G-CON PODs will be customised with advanced Pall Biotech bioprocessing equipment, including automation and utility supplies; these will be predesigned into the G-CON cleanroom units for scalable deployment.

“Together, Pall’s cutting-edge technology and G-CON’s flexible cleanroom platform take the concept of modularity one step further, delivering a complete, reproducible, scalable facility solution that is easy to place or relocate, as well as clean, sanitise and even repurpose,” said Mario Philips, VP and General Manager at Pall Biotech.

“This strategic collaboration is particularly important to Pall, as we continuously improve bioprocesses for the industry by offering innovative solutions like G-CON PODs customised with Pall technologies. This solution addresses customer demand for higher efficiencies, while enjoying more flexibility through scale-out and localisation of manufacturing.”

PODs from G-CON are mobile and include integrated process piping, and heating and air conditioning (HVAC) systems.

The customised PODs allow a customer to focus on the target molecule, while relying on the G-CON and Pall teams to optimise the facility design and process. Once designed, the PODs ease verification, qualification and validation challenges by providing comprehensive site acceptance testing and even IQ/OQ support. The PODs’ flexibility allows them to support multiple products. The cost of building a facility is drastically reduced, as is build time, which increases the return on investment.

“G-CON’s prefabricated cleanroom units feature a complete, yet compressed footprint for Pall’s continuous bioprocessing and viral vector production designs. The implementation of the Pall processes into our POD infrastructure creates an ideal turnkey solution for our customers. These solutions will be readily deployable and scalable, as they reduce the typical design, verification and qualification efforts by standardising processes and cleanroom environments,” said Maik Jornitz, President and CEO of G-CON Manufacturing.

“We are looking forward to combining our PODs with Pall’s process knowledge and designs to serve our joint customer base. The industry requires optimised, fast, scalable solutions and these requirements will be met through this collaboration.”

You may also like